Erasca Inc (ERAS)

Erasca Inc (ERAS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $5.1B; returns 1 day +2.5%, 1 week +7.5%, 1 year +551.1%.

Erasca Inc. is a clinical-stage precision oncology company headquartered in San Diego, California, singularly focused on discovering, developing, and commercializing novel small molecule therapies for patients with RAS/MAPK pathway-driven cancers.

Groups ERAS belongs to

• Healthcare
• Biotechnology
• Oncology
• Precision Medicine
• Clinical Stage Biotech
• Biopharmaceutical
• Cancer Therapeutics
• Drug Discovery
• Clinical Stage
• Life Sciences
• Pharmaceuticals

ERAS financial model: income statement, cash flow and balance sheet